Vardenafil

BNF:
7.4.5
Status:
Grey
Decision Date:
None
 

Comments

 GREY: PDE5 inhibitors are generally considered equivalent. 2nd line choice for patients intolerant to sildenafil (1st line) should be based on cost (decision date - May 2014)

GREY:5 Orodispersible - should be reserved for those with true dysphagia with choice based on cost (decision date - March 2012)

Grey Drug Classifications

  • 5: Less cost-effective than current standard therapy

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app